Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test
- PMID: 16084257
- DOI: 10.1016/S0140-6736(05)66793-1
Detection of arsenical drug resistance in Trypanosoma brucei with a simple fluorescence test
Abstract
The resurgence of human African trypanosomiasis (HAT), coupled with an increased incidence of drug resistance, is of concern. We report a quick, simple, and sensitive test for identification of parasites resistant to melarsoprol, the main drug used to treat late stage HAT. Resistant parasites are defective in a plasma membrane transporter responsible for drug uptake. The same transporter carries the fluorescent diamidine DB99 (2,5-bis-(4-amidinophenyl)-3,4-dimethylfuran) into trypanosomes. The two DNA-containing structures in the trypanosome--the nucleus and the kinetoplast--begin to fluoresce within 1 min of introduction of DB99, unless drug resistant.
Comment in
-
Fast, simple, and low-cost test for drug-resistant pathogens.Lancet. 2005 Aug 6-12;366(9484):437-8. doi: 10.1016/S0140-6736(05)66833-X. Lancet. 2005. PMID: 16084237 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
